Impact of erythropoietin on the effects of irradiation under hypoxia

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 11, 2009, Pages 1615-1623

  Lo Nigro, Cristiana ^a   Maffi, Monica ^a   Fischel, Jean Louis ^b   Monteverde, Martino ^a   Catarsi, Paolo ^a   Tonissi, Federica ^a   Lattanzio, Laura ^a   Riba, Michela ^a   Etienne Grimaldi, Marie Christine ^b   Formento, Patricia ^b   Milano, Gerard ^b   Merlano, Marco ^a  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

EGFR; Erythropoietin; Head and neck carcinoma cell line; Hypoxia; Radioresistance

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERYTHROPOIETIN RECEPTOR; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN; XRCC1 PROTEIN; DNA BINDING PROTEIN; ERYTHROPOIETIN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA REPAIR; DOWN REGULATION; ENZYME PHOSPHORYLATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; CELL HYPOXIA; CELL PROTECTION; DRUG EFFECT; HEAD AND NECK TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; TUMOR CELL LINE;

APOPTOSIS; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; CYTOPROTECTION; DNA REPAIR; DNA-BINDING PROTEINS; ERYTHROPOIETIN; HEAD AND NECK NEOPLASMS; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ERYTHROPOIETIN;

EID: 70349565955     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0609-1     Document Type: Article

References (41)

1. G Acs PJ Zhang CM McGrath, et al. 2003 Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression Am J Pathol 162 1789 1806 12759237 1:CAS:528:DC%2BD3sXkvVyjsbg%3D
2. G Acs X Xu C Chu P Acs A Verma 2004 Prognostic significance of erythropoietin expression in human endometrial carcinoma Cancer 100 2376 2386 10.1002/cncr.20244 15160341 10.1002/cncr.20244 1:CAS:528:DC%2BD2cXltFajsrw%3D (Pubitemid 38657885)
3. AI Belenkov G Shenouda E Rizhevskaya, et al. 2004 Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin Mol Cancer Ther 3 1525 1532 15634645 1:CAS:528:DC%2BD2MXmtV2r
4. J Bussink AJ van der Kogel JH Kaanders 2008 Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer Lancet Oncol 9 288 296 10.1016/S1470-2045(08)70073-1 18308254 10.1016/S1470-2045(08)70073-1 1:CAS:528:DC%2BD1cXivVaqtb0%3D (Pubitemid 351722948)
5. J Carmichael WG DeGraff AF Gazdar JD Minna JB Mitchell 1987 Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing Cancer Res 47 936 942 3802100 1:CAS:528: DyaL2sXhsVyrtb0%3D (Pubitemid 17027905)
6. M Cazzola Y Beguin J Kloczko I Spicka B Coiffier 2003 Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production Br J Haematol 122 386 393 10.1046/j.1365-2141.2003.04439.x 12877665 10.1046/j.1365-2141.2003. 04439.x 1:CAS:528:DC%2BD3sXmvFyns70%3D (Pubitemid 36951622)
7. J Chen SM Jacobs-Helber DL Barber ST Sawyer 2004 Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase-ERK-1/2 and does not require tyrosine docking sites in the EPO receptor Exp Cell Res 298 155 166 10.1016/j.yexcr.2004. 04.009 15242770 10.1016/j.yexcr.2004.04.009 1:CAS:528:DC%2BD2cXlsFygs7o%3D (Pubitemid 38887315)
8. NA Cohen SY Lai AF Ziober BL Ziober 2004 Dysregulation of hypoxia inducible factor-1 alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential Laryngoscope 114 418 423 10.1097/00005537- 200403000-00006 15091212 10.1097/00005537-200403000-00006 1:CAS:528: DC%2BD2cXivFKjsrg%3D (Pubitemid 38391902)
9. EA Dunlop MJ Percy MP Boland AP Maxwell TR Lappin 2006 Induction of signaling in non-erythroid cells by pharmacological levels of erythropoietin Neurodegener Dis 3 94 100 10.1159/000092099 16909043 10.1159/000092099 1:CAS:528:DC%2BD28XkslSktbw%3D (Pubitemid 43760374)
10. BL Ebert HF Bunn 1999 Regulation of the erythropoietin gene Blood 94 1864 1877 10477715 1:CAS:528:DyaK1MXlvFCnurg%3D
11. L Feldman Y Wang JS Rhim, et al. 2006 Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells Prostate 66 135 145 10.1002/pros.20310 16161153 10.1002/pros.20310 1:CAS:528:DC%2BD28Xhs1KmsL4%3D (Pubitemid 43191235)
12. A Franovic L Gunaratnam K Smith, et al. 2007 Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer Proc Natl Acad Sci USA 104 13092 13097 10.1073/pnas.0702387104 17670948 10.1073/pnas.0702387104 1:CAS:528: DC%2BD2sXpt1Ghu70%3D (Pubitemid 351737598)
13. L Gunaratnam M Morley A Franovic, et al. 2003 Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells J Biol Chem 278 44966 44974 10.1074/jbc.M305502200 12944410 10.1074/jbc.M305502200 1:CAS:528:DC%2BD3sXoslWltrc%3D (Pubitemid 37377256)
14. R Haq A Halupa BK Beattie, et al. 2002 Regulation of erythropoietin- induced STAT serine phosphorylation by distinct mitogen-activated protein kinases J Biol Chem 277 17359 17366 10.1074/jbc.M201842200 11875080 10.1074/jbc.M201842200 1:CAS:528:DC%2BD38XjslWgsbw%3D (Pubitemid 34967772)
15. M Hedenus M Adriansson J San Miguel, et al. 2003 Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study Br J Haematol 122 394 403 10.1046/j.1365-2141.2003.04448.x 12877666 10.1046/j.1365-2141.2003.04448.x 1:CAS:528:DC%2BD3sXmvFyns7o%3D (Pubitemid 36951623)
16. M Henke R Laszig C Rübe, et al. 2003 Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial Lancet 362 1255 1260 10.1016/S0140- 6736(03)14567-9 14575968 10.1016/S0140-6736(03)14567-9 1:CAS:528: DC%2BD3sXot1Cjt7o%3D (Pubitemid 37324251)
17. M Henke D Mattern M Pepe, et al. 2006 Do erythropoietin receptors on cancer cells explain unexpected clinical findings? J Clin Oncol 24 4708 4713 10.1200/JCO.2006.06.2737 17028293 10.1200/JCO.2006.06.2737 1:CAS:528: DC%2BD28XhtFynsr3P (Pubitemid 46630934)
18. C Hennequin 2006 Erythropoietin and radiation therapy Bull Cancer 93 495 499 16777628 1:CAS:528:DC%2BD28XnsVyhurc%3D
19. C Lacombe P Mayeux 1998 Biology of erythropoietin Haematologica 83 724 732 9793257 1:CAS:528:DyaK1MXltlSl
20. KR Laderoute TD Grant BJ Murphy RM Sutherland 1992 Enhanced epidermal growth factor receptor synthesis in human squamous carcinoma cells exposed to low levels of oxygen Int J Cancer 52 428 432 10.1002/ijc.2910520317 1399119 10.1002/ijc.2910520317 1:CAS:528:DyaK3sXitFSgtL0%3D
21. KR LaMontagne J Butler DJ Marshall, et al. 2006 Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models Mol Cancer Ther 5 347 355 10.1158/1535-7163.MCT-05-0203 16505108 10.1158/1535-7163.MCT-05-0203 1:CAS:528:DC%2BD28XhvVelsLw%3D
22. Leyland-Jones B, BEST Investigators and Study Group (2003) Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 4:459-460. doi: 10.1016/S1470-2045(03)01163-X (Pubitemid 37009952)
23. B Leyland-Jones V Semiglazov M Pawlicki, et al. 2005 Maintaining normal hemoglobin levels with epoetin α in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study J Clin Oncol 23 5960 5972 10.1200/JCO.2005.06.150 16087945 10.1200/JCO.2005.06.150 1:CAS:528:DC%2BD2MXhtVKgtb3M (Pubitemid 46300213)
24. TJ Littlewood 2001 The impact of hemoglobin levels on treatment outcomes in patients with cancer Semin Oncol 28 49 53 10.1016/S0093-7754(01)90213-1 11395853 10.1016/S0093-7754(01)90213-1 1:STN:280:DC%2BD3MzivVSgsQ%3D%3D
25. H Ludwig 2004 rHuEPO and treatment outcomes: the preclinical experience Oncologist 9 48 54 10.1634/theoncologist.9-90005-48 15591422 10.1634/theoncologist.9-90005-48 1:CAS:528:DC%2BD2MXltVWktg%3D%3D (Pubitemid 39658345)
26. JW McBroom G Acs GS Rose, et al. 2005 Erythropoietin receptor function and expression in epithelial ovarian carcinoma Gynecol Oncol 99 571 577 10.1016/j.ygyno.2005.06.038 16051335 10.1016/j.ygyno.2005.06.038 1:CAS:528:DC%2BD2MXht1GisbfO (Pubitemid 41686538)
27. J Mendelshon 2002 Targeting the epidermal growth factor receptor for cancer therapy J Clin Oncol 20 1s 13s
28. H Nishi KH Nishi AC Johnson 2002 Early growth response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia Cancer Res 62 827 834 11830539 1:CAS:528:DC%2BD38Xht1Kru7s%3D
29. F Pajonk A Weil A Sommer R Suwinski M Henke 2004 The erythropoietin- receptor pathway modulates survival of cancer cells Oncogene 23 8987 8991 10.1038/sj.onc.1208140 15480420 10.1038/sj.onc.1208140 1:CAS:528: DC%2BD2cXhtVWgtbzN (Pubitemid 39657789)
30. HP Rodemann K Dittmann M Toulany 2007 Radiation-induced EGFR-signaling and control of DNA-damage repair Int J Radiat Biol 83 781 791 10.1080/09553000701769970 18058366 10.1080/09553000701769970 1:CAS:528:DC%2BD2sXhtl2is7fM (Pubitemid 350219102)
31. V Rosti P Pedrazzoli L Ponchio, et al. 1993 Effect of recombinant human erythropoietin on hematopoietic and non-hematopoietic malignant cell growth in vitro Haematologica 78 208 212 8294051 1:CAS:528:DyaK2cXks1Kntw%3D%3D
32. E Selzer V Wacheck R Kodym, et al. 2000 Erythropoietin receptor expression in human melanoma cells Melanoma Res 10 421 426 10.1097/00008390- 200010000-00003 11095402 10.1097/00008390-200010000-00003 1:CAS:528: DC%2BD3cXosFShtLw%3D (Pubitemid 30836824)
33. AM Sinclair N Rogers L Busse, et al. 2008 Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells Br J Cancer 98 1059 1067 10.1038/sj.bjc.6604220 18349818 10.1038/sj.bjc.6604220 1:CAS:528:DC%2BD1cXjtlGkt7c%3D
34. DE Swinson JL Jones G Cox, et al. 2004 Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways Int J Cancer 111 43 50 10.1002/ijc.20052 15185341 10.1002/ijc.20052 1:CAS:528:DC%2BD2cXlsFWrtLw%3D (Pubitemid 38859281)
35. PA Tilbrook SP Klinken 1999 The erythropoietin receptor Int J Biochem Cell Biol 31 1001 1005 10.1016/S1357-2725(99)00071-0 10582333 10.1016/S1357-2725(99)00071-0 1:CAS:528:DyaK1MXmsVWitr0%3D (Pubitemid 29454540)
36. M Toulany K Dittmann B Fehrenbacher, et al. 2008 PI3 K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro DNA Repair (Amst) 7 1746 1756 10.1016/j.dnarep.2008.06.017 10.1016/j.dnarep.2008.06.017 1:CAS:528: DC%2BD1cXhtFCrsrrF
37. M Um AW Gross HF Lodish 2007 A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells Cell Signal 19 634 645 10.1016/j.cellsig.2006.08.014 17045782 10.1016/j.cellsig.2006.08.014 1:CAS:528:DC%2BD2sXntlCksQ%3D%3D (Pubitemid 46107815)
38. C Westenfelder RL Baranowski 2000 Erythropoietin stimulates proliferation of human renal carcinoma cells Kidney Int 58 647 657 10.1046/j.1523-1755.2000. 00211.x 10916088 10.1046/j.1523-1755.2000.00211.x 1:CAS:528:DC%2BD3cXlvFagsrs%3D (Pubitemid 30620014)
39. TE Witzig PT Silberstein CL Loprinzi, et al. 2005 Phase III, randomized, double-blind study of epoetin α compared with placebo in anemic patients receiving chemotherapy J Clin Oncol 23 2606 2617 10.1200/JCO.2004.10.020 15452187 10.1200/JCO.2004.10.020 1:CAS:528:DC%2BD2MXktleqsbc%3D (Pubitemid 46179449)
40. JR Woodburn 1999 The epidermal growth factor receptor and its inhibition in cancer therapy Pharmacol Ther 82 241 250 10.1016/S0163-7258(98)00045-X 10454201 10.1016/S0163-7258(98)00045-X 1:CAS:528:DyaK1MXjvFOhtLw%3D (Pubitemid 29255919)
41. F Zolzer C Streffer 2002 Increased radiosensitivity with chronic hypoxia in four human tumor cell lines Int J Radiat Oncol Biol Phys 54 910 920 10.1016/S0360-3016(02)02963-2 12377345